Categories: Market Watch

GBB Drink Labs Initiates $53 Million Lawsuit Against FSD Biosciences Inc. For Trade Secret Misappropriation

Miami, FL, December 5, 2023 — GBB Drink Labs, a leader in innovative beverage solutions, has officially filed a lawsuit against FSD Biosciences Inc. in response to the blatant non-compliance with a Cease-and-Desist letter issued on April 14th, 2023. The lawsuit, formally submitted on May 1st, 2023, in the U.S. District Court for the Southern District of Florida, seeks $53 million in damages for a material breach of a mutual nondisclosure agreement and trade secret misappropriation.

The legal action stems from seven months of collaborative discussions between GBB Drink Labs and FSD Pharma, exploring a business opportunity related to GBB’s groundbreaking blood alcohol detoxification drink. FSD Pharma’s public disclosure of the misappropriation of GBB’s trade secrets, without crucial information, during the launch of a new research and development program has led to the initiation of legal proceedings.

The lawsuit alleges that FSD Pharma not only misused GBB’s proprietary and confidential material to attract capital and renowned entrepreneurs but also artificially inflated the price of FSD Pharma’s publicly traded stock. GBB Drink Labs, responding strongly to these actions, is seeking compensatory and punitive damages, coupled with an injunction to prevent any further unlawful disclosure and use of GBB’s trade secrets.

The case, officially titled GBB DRINK LAB, INC. v. FSD BIOSCIENCES INC., has been assigned case number 0:23-cv-60800-AHS in the U.S. District Court for the Southern District of Florida.

For more information on the case, please visit www.sinkingstocks.com.

About GBB Drink Labs: GBB Drink Labs boasts a patented formula that accelerates the process of converting alcohol to sugar in the body, facilitating rapid blood alcohol detoxification. The company has dedicated years to developing a proprietary drink, culminating in a successful acquisition of its patents by Jupiter Wellness, Inc. The closing date for the acquisition is set for August 11th, 2023, with Jupiter Wellness proudly introducing the world’s first rapid blood alcohol detoxification product, “Safety Shot.”

Information contained on this page is provided by an independent third-party content provider. eTrendystock make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please email at contact@etrendystock.com

BTW

Recent Posts

SharpLink Nets $33M in Ether Staking

SharpLink Gaming has earned $33 million from Ether staking in the past seven months. The…

2 days ago

Kirk Kendall Brings Engineering Discipline and Project Management Precision to Complex Industrial Builds

Torbay, Canada, 8th January 2026, ZEX PR WIRE, Kirk Kendall is a mechanical engineer and project management…

2 days ago

Hungary crypto crackdown deepens as more platforms exit

Hungary’s crypto market is shrinking again as more platforms pull back under a national rule…

3 days ago

Barclays invests in Ubyx as 2026 stablecoin rails grow

Barclays invests in Ubyx for stablecoin clearing Barclays has taken a stake in Ubyx, a…

3 days ago

DFlow’s Daily Integration Campaign Targets Top 3 Solana DEX Aggregator in 2026

Daily integrations pledge aims for top 3 status In an early 2026 social post captured…

5 days ago

Ethereum Stablecoin Transfers Surge to $8 Trillion in Q4 2025

Record stablecoin transfer activity on Ethereum The Ethereum network processed a record volume of stablecoin…

6 days ago